Picture
![A preview a05b578d-e1ba-4317-9212-cbf27df6de07.jpg picture a05b578d-e1ba-4317-9212-cbf27df6de07.jpg picture](/cris/rp/fileservice/rp00189/64/?filename=a05b578d-e1ba-4317-9212-cbf27df6de07.jpg)
Full Name
Baran, Yusuf
Variants
Baran, Y.
Baran, Y
Baran, Y
Main Affiliation
Email
yusufbaran@iyte.edu.tr
Other emails
ORCID
Link to Google Profile
Researcher ID
Semantic Scholar ID
145787618
Scopus Author ID
Link to YOK Profile
Personal Site
Interests
Kanser moleküler biyolojisi
Lösemi genetiği
Çoklu ilaç direnç mekanizmaları
Biyoaktif sfingolipidler
Lösemi genetiği
Çoklu ilaç direnç mekanizmaları
Biyoaktif sfingolipidler
![](/image/cris/bar-loader.gif)
Biography
Prof. Dr. Yusuf Baran is a member of The Global Young Academy, an Executive Committee member of the World Science Academy’s Board of Young Affiliates (2016-Present), a founding member of the Developing World Academy of Engineering and Technology (2016-Present), a member of the World Association of Young Scientists (2015-Present), and a member of the World Economic Forum’s Young Scientists Program (2013-Present). He was also a member of the TÜBİTAK Advisory Board from 2010 to 2015. In addition, he has held various other appointments, including ambassador for the International Young Scientist Program and advisory board member of the Academic & Scientific Cooperation Project of Turkey.
Prof. Dr. Yusuf Baran has been serving as President of Izmir Institute of Technology and Chairman of the Board of Directors of the Izmir Technology Development Zone since October 20th, 18.
Prof. Dr. Yusuf Baran has been serving as President of Izmir Institute of Technology and Chairman of the Board of Directors of the Izmir Technology Development Zone since October 20th, 18.
![](/image/cris/bar-loader.gif)
CV
Country
Turkey
Status
Current Staff
Results 61-80 of 85 (Search time: 0.061 seconds).
Issue Date | Title | Author(s) | |
---|---|---|---|
61 | Sep-2011 | Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells | Avcı, Çığır Biray; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray; Dodurga, Yavuz; Ekiz, Hüseyin Atakan ; Kartal, Melis; Şahin, Fahri; Baran, Yusuf ; Gündüz, Cumhur |
62 | 2013 | Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest | Adan Gökbulut, Aysun ; Apohan, Elif; Baran, Yusuf |
63 | May-2011 | Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells | Kartal Yandım, Melis; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
64 | Sep-2015 | Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A | Tezcanlı Kaymaz, Burçin; Selvi Günel, Nur; Ceyhan, Metin; Bozok Çetintaş, Vildan; Özel, Buket; Kartal Yandım, Melis; Kıpçak, Sezgi; Aktan, Çağdaş; Adan Gökbulut, Aysun ; Baran, Yusuf ; Kosova Can, Buket |
65 | Mar-2012 | Role of autophagy in the progression and suppression of leukemias | Ekiz, Hüseyin Atakan ; Can, Geylani; Baran, Yusuf |
66 | Oct-2011 | The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells | Güçlüler, Gözde; Pişkin, Özden; Baran, Yusuf |
67 | Feb-2011 | The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells | Çakır, Zeynep; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
68 | Aug-2011 | Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
69 | Jul-2013 | The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinibresistant chronic myeloid leukemia cells | Bozkurt, Süreyya; Özkan, Tülin; Özmen, Füsun; Baran, Yusuf ; Sunguroglu, Asuman; Kansu, Emin |
70 | Apr-2013 | The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy | Baran, Yusuf ; Ceylan, Çağatay ; Camgöz, Aylin |
71 | Jun-2011 | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A | Salas, Arelis; Ponnusamy, Suriyan; Senkal, Can E.; Meyers-Needham, Marisa; Selvam, Shanmugam Panneer; Saddoughi, Sahar A.; Apohan, Elif; Sentelle, R. David; Smith, Charles; Gault, Christopher R.; Obeid, Lina M.; El-Shewy, Hesham M.; Oaks, Joshua; Santhanam, Ramasamy; Marcucci, Guido; Baran, Yusuf ; Mahajan, Sandeep; Fernandes, Daniel; Stuart, Robert; Perrotti, Danilo; Öğretmen, Besim |
72 | Jul-2013 | STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells | Kiper, Hatice Demet; Tezcanlı Kaymaz, Burçin; Adan Gökbulut, Aysun ; Selvi, Nur; Biray Avcı, Çığır; Kosova, Buket; İskender, Güniz; Kartal Yandım, Melis; Gündüz, Cumhur; Şahin, Fahri; Baran, Yusuf ; Saydam, Güray |
73 | Oct-2010 | Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells | Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur; Dalmızrak, Ayşegül; Yandım, Melis Kartal; Gündüz, Ufuk; Baran, Yusuf |
74 | 2020 | Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cells | Kaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf |
75 | Jan-2017 | Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives | Apohan, Elif; Yılmaz, Ülkü; Yılmaz, Özgür; Serindağ, Ayfer; Küçükbay, Hasan; Yeşilada, Özfer; Baran, Yusuf |
76 | Jan-2016 | T cells in tumor microenvironment | Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
77 | Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
78 | Oct-2011 | Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation | Baran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim |
79 | Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
80 | May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |